Anakinra for severe forms of COVID-19 Reply

被引：0
|
作者：
Hayem, Gilles [1 ]
Huet, Thomas [1 ]
Jouveshomme, Stephane [2 ]
Beaussier, Helene [3 ]
Chatellier, Gilles [5 ]
Mourad, Jean-Jacques [4 ]
机构：
[1] Hop Paris St Joseph, Dept Rheumatol, F-75014 Paris, France
[2] Hop Paris St Joseph, Dept Pulmonol, F-75014 Paris, France
[3] Hop Paris St Joseph, Clin Res Ctr, F-75014 Paris, France
[4] Hop Paris St Joseph, Dept Internal Med, F-75014 Paris, France
[5] Univ Paris, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Paris, France
来源：
LANCET RHEUMATOLOGY | 2020年 / 2卷 / 10期
关键词：
D O I：
10.1016/S2665-9913(20)30274-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E587 / E588
页数：3
相关论文
共 50 条
  • [21] The Role of Platelet in Severe and Fatal Forms of COVID-19
    Esparza-Ibarra, Edgar L.
    Ayala-Lujan, Jorge L.
    Mendoza-Almanza, Brenda
    Gonzalez-Curiel, Irma
    Godina-Gonzalez, Susana
    Hernandez-Barrales, Marisa
    Mendoza-Almanza, Gretel
    [J]. CURRENT MOLECULAR MEDICINE, 2022, 22 (07) : 572 - 583
  • [22] The Role of Acidosis in the Pathogenesis of Severe Forms of COVID-19
    Nechipurenko, Yury D.
    Semyonov, Denis A.
    Lavrinenko, Igor A.
    Lagutkin, Denis A.
    Generalov, Evgenii A.
    Zaitceva, Anna Y.
    Matveeva, Olga, V
    Yegorov, Yegor E.
    [J]. BIOLOGY-BASEL, 2021, 10 (09):
  • [23] A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19
    Kharazmi, Amir Behnam
    Moradi, Omid
    Haghighi, Mehrdad
    Kouchek, Mehran
    Manafi-Rasi, Alireza
    Raoufi, Masoomeh
    Shoaei, Simin Dokht
    Hadavand, Fahimeh
    Nabavi, Mahmood
    Miri, Mir Mohammad
    Salarian, Sara
    Shojaei, Seyedpouzhia
    Khalili, Shayesteh
    Sistanizad, Mohammad
    Sadeghi, Setayesh
    Karagah, Amirhossein
    Asgari, Saemeh
    Jaffaraghaei, Morteza
    Araghi, Shahram
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2022, 10 (02) : 201 - 208
  • [24] Can Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?
    Karakas, Ozlem
    Erden, Abdulsamet
    Unlu, Serpil
    Erol, Seyit Ahmet
    Goncu Ayhan, Sule
    Ozdemir, Bahar
    Tanacan, Atakan
    Ozden Tokalioglu, Eda
    Ates, Ihsan
    Moraloglu Tekin, Ozlem
    Omma, Ahmet
    Sahin, Dilek
    Kucuksahin, Orhan
    [J]. WOMEN & HEALTH, 2021, 61 (09) : 872 - 879
  • [25] Anakinra in COVID-19: A step closer to the cure
    Barkas, Fotios
    Christaki, Eirini
    Liberopoulos, Evangelos
    Kosmidou, Maria
    Milionis, Haralampos
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 96 : 113 - 114
  • [26] Successful Treatment of Severe COVID-19 Pneumonia with Simultaneous Tocilizumab and Anakinra - A Case Series
    Haibel, Hildrun
    Angermair, Stefan
    Schumann, Michael
    Vahldiek, Janis
    Poddubnyy, Denis
    Schneider, Thomas
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 392 - 393
  • [27] Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
    Aouba, Achille
    Baldolli, Aurelie
    Geffray, Loik
    Verdon, Renaud
    Bergot, Emmanuel
    Martin-Silva, Nicolas
    Justet, Aurelien
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (10) : 1381 - 1381
  • [28] Current evidence on the use of anakinra in COVID-19
    Khani, Elnaz
    Shahrabi, Marzieh
    Rezaei, Haleh
    Pourkarim, Fariba
    Afsharirad, Hoda
    Solduzian, Mohammad
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 111
  • [29] Reply to: "Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection"
    Joob, Beuy
    Wiwanitkit, Viroj
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (02) : E143 - E143
  • [30] Etoposide-based therapy for severe forms of COVID-19
    Hamizi, Kamel
    Aouidane, Souhila
    Belaaloui, Ghania
    [J]. MEDICAL HYPOTHESES, 2020, 142
12345